Assessment of knowledge and awareness regarding opioid overdose and toxicity among a sample of healthcare providers-Reference-Cited by-同舟云学术

Assessment of knowledge and awareness regarding opioid overdose and toxicity among a sample of healthcare providers

Published:2022-04-08 Issue:1 Volume:22 Page:265-275
ISSN:1477-2701
Container-title:Pharmacy Education
language:
Short-container-title:Pharm Educ

Author:

Alotaibi Fahad Marzouq^ORCID,Zaitoun Mohammed Fathullah^ORCID,Alotabi Rayid Shabeeb,Alhadi Mohammed Saeed A.,AlShahrani Amani Mohammed^ORCID,Almoeed Alyah Abdullah,AlNasser Marzouq Saeed,Bamagous Ghazi^ORCID

Abstract

Background: Knowledge and attitudes of healthcare providers regarding opioid toxicity are significant concerns. Objective: Investigate the knowledge, attitudes, awareness, and comfort level regarding overdosing among a sample of healthcare providers working at the Armed Forces Hospital Southern Region (AFHSR). Methods: Anonymous surveys were administered to AFHSR staff to assess attitude, knowledge, comfort level, and fear of consequences using a 5-point scale. Participants were AFHSR primary care physicians/internists, surgeons, physician assistants/advanced practice registered nurses, and pharmacists. Results: Healthcare providers demonstrated a lack of knowledge, awareness, and fear of the consequences associated with opioid use, overdose, and the indications and administration of naloxone. This study’s findings indicate that healthcare providers are hesitant to engage in discussions with patients about preventative measures for opioid overdose, with the majority believing that doing so will make no difference in preventing opioid overdose incidence. Additionally, a distinct difference in knowledge and perceptions of opioid abuse and toxicity was found between nurses and physicians. Further, the findings indicate a difference in knowledge and awareness regarding opioid overdose and toxicity between nurses and pharmacists.

Publisher

International Pharmaceutical Federation (FIP)

Subject

Pharmaceutical Science,Pharmacy,Education,Pharmaceutical Science,Pharmacy,Education

Reference38 articles.

1. Bazazi, A. R., Zaller, N. D., Fu, J. J., & Rich, J. D. (2010). Preventing opiate overdose deaths: examining objections to take-home naloxone. Journal of health care for the poor and underserved, 21(4), 1108

2. Behar, E., Bagnulo, R., & Coffin, P. O. (2018). Acceptability and feasibility of naloxone prescribing in primary care settings: A systematic review. Preventive medicine, 114, 79-87. https://doi.org/10.1016/j.ypmed.2018.06.005

3. Binswanger, I. A., Koester, S., Mueller, S. R., Gardner, E. M., Goddard, K., & Glanz, J. M. (2015). Overdose education and naloxone for patients prescribed opioids in primary care: a qualitative study of primary care staff. Journal of general internal medicine, 30(12), 1837-1844. https://doi.org/10.1007/s11606-015-3394-3

4. Bohnert, A. S., Valenstein, M., Bair, M. J., Ganoczy, D., McCarthy, J. F., Ilgen, M. A., & Blow, F. C. (2011). Association between opioid prescribing patterns and opioid overdose-related deaths. JAMA, 305(13), 1315-1321. https://doi.org/10.1001/jama.2011.370

5. Bounthavong, M., Suh, K., Christopher, M. L., Veenstra, D. L., Basu, A., & Devine, E. B. (2020). Providers' perceptions on barriers and facilitators to prescribing naloxone for patients at risk for opioid overdose after implementation of a national academic detailing program: A qualitative assessment. Research in Social and Administrative Pharmacy, 16(8), 1033-1040. https://doi.org/10.1016/j.sapharm.2019.10.015